This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEIA80MC_L.jpg
(Reuters) – Britain’s medicines regulator on Wednesday approved an adapted COVID-19 vaccine from U.S. drugmaker Pfizer (NYSE:PFE) and German partner BioNTech as a booster.
The shot targets the original coronavirus as well as Omicron BA.4 and BA.5 sub-variants.
